Baseline plasma matrix metalloproteinase 9 (MMP9) to predict overall survival (OS) benefit from bevacizumab (BEV) in newly diagnosed glioblastoma (GBM): Retrospective analysis of AVAglio. This is an ...
Please provide your email address to receive an email when new articles are posted on . SEATTLE — A laboratory study showed significant variation in accuracy and residual volume among syringes ...
Trastuzumab Rezetecan in Human Epidermal Growth Factor Receptor 2–Expressing Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer: A Multicenter, Open-Label, Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results